AK Medical Holdings Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	339.09	273.93	182.1	204.77	92.62
Depreciation & Amortization	105.57	94.77	88.89	78.44	71.54
Other Amortization	1.31	1.56	2.05	1.96	2.62
Loss (Gain) From Sale of Assets	0.63	2.27	0.17	0.13	0.52
Asset Writedown & Restructuring Costs	-	-	-	18.36	-
Stock-Based Compensation	7.63	8.78	5.06	8.13	1.05
Provision & Write-off of Bad Debts	22.05	21.58	13.7	10.49	-1.11
Other Operating Activities	-24.15	-19.56	-22.5	-39.03	-21.64
Change in Accounts Receivable	-139.54	-69.67	3.33	-26.82	23.12
Change in Inventory	29.45	106.85	-193.18	20.74	-62.36
Change in Accounts Payable	47.82	-30.05	19.75	62.4	-53
Change in Unearned Revenue	-17.18	17.61	5.45	-87.57	121.01
Change in Other Net Operating Assets	23.29	43.02	-70.89	-9.09	2.25
Operating Cash Flow	395.98	451.07	33.94	242.92	176.62
Operating Cash Flow Growth	-12.21%	1229.22%	-86.03%	37.54%	-13.95%
Capital Expenditures	-105.67	-152.82	-183.8	-115.2	-58.76
Sale of Property, Plant & Equipment	1.01	0.39	0.31	0.06	2.89
Sale (Purchase) of Intangibles	-18.31	-9.15	-12.28	-6.52	-17.47
Investment in Securities	-202.86	-256.6	-141.02	20.78	-236.39
Other Investing Activities	21.22	24.83	18.63	18.58	12.63
Investing Cash Flow	-304.61	-393.35	-318.15	-82.29	-297.1
Long-Term Debt Issued	78.38	49.7	58.8	-	-
Total Debt Issued	78.38	49.7	58.8	-	-
Long-Term Debt Repaid	-89.53	-41.32	-18.43	-10.72	-12.79
Total Debt Repaid	-89.53	-41.32	-18.43	-10.72	-12.79
Net Debt Issued (Repaid)	-11.15	8.38	40.38	-10.72	-12.79
Issuance of Common Stock	2.74	0.94	8.93	0.06	0.22
Repurchase of Common Stock	-	-	-	-	-49.83
Common Dividends Paid	-73.63	-46.1	-61.51	-23.96	-36.69
Other Financing Activities	-3.43	-2.65	-1.82	-2.17	-1.61
Financing Cash Flow	-85.47	-39.43	-14.02	-36.8	-100.7
Foreign Exchange Rate Adjustments	-0.84	2.66	3.62	26.39	-16.3
Net Cash Flow	5.06	20.96	-294.61	150.22	-237.49
Free Cash Flow	290.31	298.25	-149.86	127.72	117.86
Free Cash Flow Growth	-2.66%	-	-	8.36%	-1.79%
Free Cash Flow Margin	19.58%	22.15%	-13.70%	12.14%	15.48%
Free Cash Flow Per Share	0.26	0.27	-0.13	0.11	0.10
Cash Interest Paid	0.45	0.92	1.29	2.17	1.61
Cash Income Tax Paid	51.59	41.62	46.07	57.21	29.06
Levered Free Cash Flow	-23.63	285.75	-154.43	129.07	40.55
Unlevered Free Cash Flow	-21.79	286.33	-153.63	130.43	41.56
Change in Working Capital	-56.16	67.74	-235.53	-40.34	31.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.